Cargando…

First Melody® valve implantations in Africa

Congenital heart lesions involving the right ventricular outflow tract (RVOT) are a common problem in paediatric cardiology. These patients need multiple surgical interventions in the form of valved conduits over a lifetime. Surgical re-valvulation was the standard treatment option until the introdu...

Descripción completa

Detalles Bibliográficos
Autores principales: Buys, DG, Greig, C, Brown, SC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683341/
https://www.ncbi.nlm.nih.gov/pubmed/26407223
http://dx.doi.org/10.5830/CVJA-2015-007
_version_ 1782406008454250496
author Buys, DG
Greig, C
Brown, SC
author_facet Buys, DG
Greig, C
Brown, SC
author_sort Buys, DG
collection PubMed
description Congenital heart lesions involving the right ventricular outflow tract (RVOT) are a common problem in paediatric cardiology. These patients need multiple surgical interventions in the form of valved conduits over a lifetime. Surgical re-valvulation was the standard treatment option until the introduction of percutaneous pulmonary valves over a decade ago. These valves can be used to prolong the lifespan of conduits and reduce the number of re-operations. The Melody® valve (Medtronic, Minneapolis, MN, USA) was introduced as the first dedicated percutaneous pulmonary valve. Percutaneous pulmonary valves can be implanted successfully and have the advantage of short hospitalisations. We describe the first three Melody® valve implantations in Africa.
format Online
Article
Text
id pubmed-4683341
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-46833412016-02-10 First Melody® valve implantations in Africa Buys, DG Greig, C Brown, SC Cardiovasc J Afr Case Report Congenital heart lesions involving the right ventricular outflow tract (RVOT) are a common problem in paediatric cardiology. These patients need multiple surgical interventions in the form of valved conduits over a lifetime. Surgical re-valvulation was the standard treatment option until the introduction of percutaneous pulmonary valves over a decade ago. These valves can be used to prolong the lifespan of conduits and reduce the number of re-operations. The Melody® valve (Medtronic, Minneapolis, MN, USA) was introduced as the first dedicated percutaneous pulmonary valve. Percutaneous pulmonary valves can be implanted successfully and have the advantage of short hospitalisations. We describe the first three Melody® valve implantations in Africa. Clinics Cardive Publishing 2015 /pmc/articles/PMC4683341/ /pubmed/26407223 http://dx.doi.org/10.5830/CVJA-2015-007 Text en Copyright © 2015 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Buys, DG
Greig, C
Brown, SC
First Melody® valve implantations in Africa
title First Melody® valve implantations in Africa
title_full First Melody® valve implantations in Africa
title_fullStr First Melody® valve implantations in Africa
title_full_unstemmed First Melody® valve implantations in Africa
title_short First Melody® valve implantations in Africa
title_sort first melody® valve implantations in africa
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683341/
https://www.ncbi.nlm.nih.gov/pubmed/26407223
http://dx.doi.org/10.5830/CVJA-2015-007
work_keys_str_mv AT buysdg firstmelodyvalveimplantationsinafrica
AT greigc firstmelodyvalveimplantationsinafrica
AT brownsc firstmelodyvalveimplantationsinafrica